mRNA |
17-AAG |
CCLE |
pan-cancer |
AAC |
0.098 |
0.03 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.03 |
mRNA |
Dasatinib |
FIMM |
pan-cancer |
AAC |
0.35 |
0.04 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.04 |
mRNA |
BRD-K07442505 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.04 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |